no news_id given

Tech Review

01.02.2010

The market share of ultrafast sequencing machines on the total sequencing market is set to expand rapidly. In April 2010, Roche daughter 454 Life Sciences (Branford, US) is launching a new system especially designed for...

Tech Review

01.02.2010

Luxembourg has appeared from nowhere with an initiative to set up a European center for diagnostic biomarkers, while it’s government has set aside EUR140m to reach some ambitious goals. To speed up development, Luxembourg looked...

Tech Review

01.02.2010

Systems biology is aimed at achieving a holistic understanding of living organisms, while synthetic biology seeks to design and construct new living organisms with targeted functionalities. Genome sequencing and the fields of...

Politics / Law

01.02.2010

Europe is to receive a new Super Commissioner for biotech, as well as the largest budget for research the bloc has ever granted. Even before the start of hearings considering the 26 Commission nominees that began in mid-January,...

Editorial

01.02.2010

The new EU Commissioner-Delegate for Health and Consumer Policy made his case to the European Parliament in January, and has now been granted a revamped portfolio of previously distinct health-related organisations and...

BioFunding

26.01.2010

Reykjavik – Iceland's deCode Genetics has reimmerged as a private biotechnology company following its purchase from its former parent company by Saga Investments LLC, a consortium that includes Polaris Ventures and ARCH Venture...

Politics / Law

31.12.2009

Darmstadt/Berlin – Cultivation of GM maize in the EU fell sharply in 2009, according to figures from transgen.de. The most active country is still Spain, which makes up more than 80% of all GM cultivation. In 2009, European...

Politics / Law, GermanyGermany

30.12.2009

Germany has launched Europe’s first civil high-throughput screening facility for high-risk infectious agents within the framework of ERA-NET PathoGenoMics. The novel bio-safety level 3 (BSL3) unit at the Max Planck Institute for...

Politics / Law

28.12.2009

Brussels/Strasbourg – John Dalli, the designated Super Commissioner for Biotechnology has set out his future priorities as Health Commissioner of the European Commission. In a document published on 23 December by the European...

Displaying results 351 to 360 out of 1983

< Previous 351-360 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/news/messages-archive/archive/browse/35.html

Events

All Events

Stock list

All quotes

TOP

  • SANTHERA74.95 CHF10.30%
  • BIOTEST80.50 EUR6.83%
  • WILEX2.22 EUR5.71%

FLOP

  • 4SC1.20 EUR-6.25%
  • VITA 343.78 EUR-2.83%
  • EPIGENOMICS3.12 EUR-2.50%

TOP

  • WILEX2.22 EUR177.5%
  • MAGFORCE6.50 EUR17.1%
  • SANTHERA74.95 CHF10.2%

FLOP

  • VITA 343.78 EUR-24.6%
  • MOLOGEN7.80 EUR-19.3%
  • PAION2.40 EUR-17.2%

TOP

  • SANTHERA74.95 CHF3647.5%
  • CO.DON2.50 EUR212.5%
  • PAION2.40 EUR182.4%

FLOP

  • CYTOS0.27 CHF-93.3%
  • MEDIGENE4.60 EUR-67.7%
  • THERAMETRICS0.08 CHF-46.7%

No liability assumed, Date: 19.08.2014


Current issue

All issues

Product of the week

Products